Drug transport kinetics of intravascular triggered drug delivery systems

被引:0
|
作者
Timo L. M. ten Hagen
Matthew R. Dreher
Sara Zalba
Ann L. B. Seynhaeve
Mohamadreza Amin
Li Li
Dieter Haemmerich
机构
[1] Erasmus Medical Center,Laboratory Experimental Oncology and Nanomedicine Innovation Center Erasmus (NICE), Department of Pathology
[2] Boston Scientific,Department of Pediatrics
[3] Medical University of South Carolina,Department of Bioengineering
[4] Clemson University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Intravascular triggered drug delivery systems (IV-DDS) for local drug delivery include various stimuli-responsive nanoparticles that release the associated agent in response to internal (e.g., pH, enzymes) or external stimuli (e.g., temperature, light, ultrasound, electromagnetic fields, X-rays). We developed a computational model to simulate IV-DDS drug delivery, for which we quantified all model parameters in vivo in rodent tumors. The model was validated via quantitative intravital microscopy studies with unencapsulated fluorescent dye, and with two formulations of temperature-sensitive liposomes (slow, and fast release) encapsulating a fluorescent dye as example IV-DDS. Tumor intra- and extravascular dye concentration dynamics were extracted from the intravital microscopy data by quantitative image processing, and were compared to computer model results. Via this computer model we explain IV-DDS delivery kinetics and identify parameters of IV-DDS, of drug, and of target tissue for optimal delivery. Two parameter ratios were identified that exclusively dictate how much drug can be delivered with IV-DDS, indicating the importance of IV-DDS with fast drug release (~sec) and choice of a drug with rapid tissue uptake (i.e., high first-pass extraction fraction). The computational model thus enables engineering of improved future IV-DDS based on tissue parameters that can be quantified by imaging.
引用
收藏
相关论文
共 50 条
  • [41] DRUG DELIVERY SYSTEMS
    DAVIS, SS
    ILLUM, L
    PRACTITIONER, 1983, 227 (1384) : 1537 - &
  • [42] Drug delivery systems
    Davis, SS
    INTERDISCIPLINARY SCIENCE REVIEWS, 2000, 25 (03) : 175 - 183
  • [43] DRUG DELIVERY SYSTEMS
    BREIMER, DD
    PHARMACY INTERNATIONAL, 1983, 4 (04): : 71 - 71
  • [44] Nanoscale transport for drug delivery
    Crombie, J
    PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES, 2006, 5 (04) : B15 - B15
  • [45] Analysis of drug transport kinetics in implications for drug action
    Garnier-Suillerot, A
    Marbeuf-Gueye, C
    Salerno, M
    Loetchutinat, C
    Fokt, I
    Krawczyk, M
    Kowalczyk, T
    Priebe, W
    CURRENT MEDICINAL CHEMISTRY, 2001, 8 (01) : 51 - 64
  • [46] DRUG DELIVERY SYSTEMS .6. TRANSDERMAL DRUG DELIVERY
    RANADE, VV
    JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (05): : 401 - 418
  • [47] In situ gelling drug delivery systems for topical drug delivery
    Kolawole, Oluwadamilola M.
    Cook, Michael T.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2023, 184 : 36 - 49
  • [49] ADVANCES IN DRUG DELIVERY - MAGNETICALLY MODULATED DRUG DELIVERY SYSTEMS
    KOST, J
    LANGER, R
    PHARMACY INTERNATIONAL, 1986, 7 (03): : 60 - 63
  • [50] DRUG DELIVERY SYSTEMS .4. IMPLANTS IN DRUG DELIVERY
    RANADE, VV
    JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (10): : 871 - 889